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The BOLD contrast mechanism has a complex relationship with functional brain activity, 
oxygen metabolism, and neurovascular factors. Accurate interpretation of the BOLD 
signal for neuroscience and clinical applications necessitates a clear understanding of 
the sources of BOLD contrast and its relationship to underlying physiology. This review 
describes the physiological components that contribute to the BOLD signal and the 
steady-state calibrated BOLD models that enable quantification of functional changes 
with a separate challenge paradigm. The principles derived from these biophysical 
models are then used to interpret BOLD measurements in different neurological 
disorders in the presence of confounding vascular factors related to disease. 
 
BOLD contrast and physiology 
The BOLD contrast in functional MRI results from the fact that oxygenated hemoglobin 
is diamagnetic, while deoxygenated hemoglobin (dHb) is paramagnetic. Because dHb is 
paramagnetic, water spins in partly deoxygenated blood experience increased 
dephasing. This dephasing attenuates the T2*-weighted signal from venous blood and 
tissue containing dHb (Ogawa et al., 1990a; Ogawa et al., 1990b). When the brain is 
performing a task, active regions consume oxygen to function, leading to a localized 
increase in dHb. To meet the need for additional oxygen, nearby blood vessels dilate, 
causing an increase in local blood flow. The inflowing blood is fully oxygenated, thereby 
diluting the dHb concentration and leading to an increased BOLD signal.  
Because the activity-driven BOLD signal increase is due to vasodilation and dilution of 
dHb, the BOLD signal conflates changes in oxidative metabolism, blood flow and blood 
volume. This hemodynamic response is thought to be tightly regulated in healthy brains, 
but changes in neurovascular coupling in aging and disease make it problematic to 
compare BOLD signals across groups (Ances et al., 2008; Ances et al., 2009; Gauthier 
et al., 2013; Hutchison et al., 2013; Liu et al., 2013; Peng et al., 2014). These group 
comparisons are problematic both because of the physiological ambiguity of the BOLD 
signal and because BOLD contrast measures a relative signal change from an unknown 
baseline. Any change in coupling or in the baseline cerebral blood flow (CBF), cerebral 
blood volume (CBV) or oxygen metabolism will result in a different BOLD signal change. 
Therefore, the vascular and metabolic sub-components should be taken into account for 
the accurate interpretation of task-evoked and resting state BOLD signal changes (Liu, 
2013).  
Underlying neuronal activity 
Functional imaging using hemodynamic methods such as BOLD contrast are based on 
the assumption that the signal changes observed are strongly correlated with underlying 
neuronal activity. Convincing evidence for this correlation comes from simultaneous 
electrophysiological and fMRI recordings in non-human primates (Logothetis et al., 
2001; Logothetis and Wandell, 2004; Shmuel et al., 2002). In these studies, electrodes 
are inserted in monkey visual cortex to record spontaneous or visual task-elicited 
activity of neuronal currents simultaneously with fMRI signal in the same areas. 















unit spiking activity, multi-unit activity (MUA) and local field potentials (LFP). An 
electrode placed in the extracellular fluid measures MUA, which is thought to represent 
spiking activity from more distant neurons. LFP activity is thought to reflect 
predominantly sub-threshold currents in the soma and dendrites of surrounding neuron 
populations, with some contributions from voltage-gated membrane oscillations and 
membrane after-potentials (Logothetis and Wandell, 2004; Magri et al., 2012).  
Early electrophysiological studies in anesthestized monkeys have established that while 
BOLD signal amplitude is correlated with all types of neuronal firing, it is more closely 
linked with local field potentials (LFPs) than with other electrical activity such as spikes 
from action potentials (Logothetis et al., 2001). While higher frequency bands such as 
gamma (40-100 Hz) were the most informative about the BOLD signal, the relative 
power distribution across the bands carries complementary information (Magri et al., 
2012). For instance, BOLD signal increases correlate with a shift in the power of LFPs 
towards higher frequencies (Magri et al., 2012), in agreement with theory (Kilner et al., 
2005). These relationships were found to be true also for BOLD signal decreases, with 
shifts towards lower frequencies indicative of a deactivation (Magri et al., 2012). 
However, studies have shown that there may be non-linearities in the relationship 
between stimuli amplitude and type, neuronal response and hemodynamic signals 
(Bartolo et al., 2011; Bentley et al., 2016; Devor et al., 2003). Taken together, these 
results illustrate a complex relationship between neuronal activity and the BOLD signal, 
such that a simple interpretation of BOLD signal in terms of activation should be 
considered cautiously.  
Oxidative metabolism 
While the BOLD signal is related to electrical activity, the signal itself arises from a 
combination of changes in blood flow, blood volume and oxidative metabolism to meet 
the energy demands of brain activity. Therefore, the contribution of oxidative 
metabolism versus aerobic glycolysis to brain energy expenditure linked to neuronal 
activity is an important consideration to understand the relationship between the BOLD 
signal and neuronal activity.  
The main energy expenditure of neurons is to maintain membrane potential in 
preparation to fire action potentials and integrate synaptic information when the need 
arises. To do so, the brain uses energy in the form of ATP, which is derived from the 
metabolism of glucose. Two forms of glucose metabolism in the presence of oxygen 
exist: aerobic glycolysis, which is faster but only produces 2 ATP molecules per 
glucose; and oxidative phosphorylation through the mitochondrial electron transport 
chain, which is highly efficient, forming as many as 38 ATP molecules from a single 
glucose molecule. Because oxidative phosphorylation is much more efficient at energy 
production and because the brain is known to be an avid user of oxygen, it was 
expected that oxidative metabolism would be the main form of metabolism used in the 
brain. Indeed, interruption of the brain's oxygen supply leads to unconsciousness within 
seconds and irreversible tissue damage within minutes as shown in a rat model (Levy et 
al., 1975). While initial Positron Emission Tomography (PET) results were consistent 
with a predominant role of aerobic glycolysis (Fox and Raichle, 1986), subsequent PET 
experiments have yielded results much more compatible with the predicted predominant 















Ibaraki et al., 2010; Ishii et al., 1996b; Ito et al., 2005; Mintun et al., 2002; Yamauchi et 
al., 2002). Brain ATP generation is now thought to occur primarily through oxidative 
phosphorylation.  
Neurovascular coupling 
Because the brain has no stores of oxygen and glucose, brain tissue must meet 
increased metabolic demands during functional activity through local CBF increases, to 
deliver metabolic substrates and remove waste. The neurovascular unit is composed of 
different cells which work together to orchestrate the blood flow increase required by 
increased metabolic demand. The neurovascular unit includes neurons, glia and 
vascular cells, including vessel endothelium, smooth muscle cells, pericytes and 
adventitial cells (Girouard and Iadecola, 2006). The signalling cascades that underlie 
this process of neurovascular coupling are complex and may be regionally dependent 
(Lecrux and Hamel, 2016). While research in this area has identified the main mediators 
and modulators of this pathway (Girouard and Iadecola, 2006; Lauritzen and Gold, 
2003; Lecrux and Hamel, 2011, 2016), their relative importance and the cellular 
environment variables that determine their function are still largely unknown. 
The regulation of blood flow via neurovascular coupling is complex and the amplitude of 
the hemodynamic response may depend strongly on the specific cellular environment of 
brain regions (Lecrux and Hamel, 2016). However, in all cases, there is some 
relationship between aspects of neuronal signalling and the release of vasoactive 
molecules. Therefore, though the exact underpinning of this blood flow response may 
be difficult to untangle, the response itself can be taken as a surrogate for neuronal 
activity. Much of our understanding about the spatial localization of neurovascular 
coupling and which blood compartments are altered during neural activity (and at what 
time) come from high-resolution, invasive optical imaging observations in rodent models 
(Berwick et al., 2005; Briers, 2001; Devor et al., 2003).  
During performance of a task, the coupling ratio between the increase in blood flow to 
the increase in oxidative metabolism is thought to be around two under normal 
circumstances (Buxton, 2010). In other words, during local brain activity in the absence 
of disease or pharmacological agents, the fractional blood flow change is thought to be 
about two times larger than the fractional change in oxidative metabolism (Buxton, 
2010; Leontiev et al., 2013). This fraction may however depend on the task, and may be 
changed in caffeine intake and disease, as well as across brain areas (Ances et al., 
2011; Perthen et al., 2008). 
 
Cerebral blood volume 
Robust increases to cerebral blood volume (CBV), the volume of blood within a brain 
region, occur during functional activation and are known to modulate the BOLD signal 
(Toronov et al., 2003). Since CBV changes are strongly correlated with changes in CBF, 
the relationship between the BOLD signal and CBV is typically inferred from observed 
changes in perfusion. This power law relationship is described by CBV ~ CBFα, where α 
is the Grubb constant and has reported values in the range of 0.38-0.50 (Eichling et al., 
1975; Malonek et al., 1997; van Zijl et al., 1998) in animal models (rhesus monkeys, 















and CBV are not matched throughout the BOLD time course, potentially creating 
transient effects such as the initial dip and post-stimulus undershoot (Mandeville et al., 
1999; van Zijl et al., 2012). Furthermore, the CBF-CBV coupling likely changes during 
gas breathing or pharmacological agents (Seifritz et al., 2000), and is known to be 
disrupted in neurological disorders such as tumors and carotid stenosis. In these 
scenarios, a direct, quantitative measurement of CBV would inform the BOLD model 
independently of perfusion measurements. 
Direct CBV measurement has been shown to be functionally sensitive across many 
parenchymal brain structures (Mandeville et al. 2001); and to localize to deep cortical 
layers (Jin and Kim, 2008). Thus, CBV as a way to map brain activity offers improved 
spatial localization than gradient-echo BOLD signal (Aaslid et al., 1984; Kim et al., 
2013), which is prone to contamination by signal from remote large veins. Highly 
sensitive sequences with MRI contrast agent (Francis et al., 2003) and without contrast 
(Donahue et al., 2006; Huber et al., 2018; Lu and van Zijl, 2012) have been developed 
for high-resolution observation of CBV. Furthermore, localization of CBV in specific 
vascular compartments would also be useful for interpretation of BOLD contrast. While 
the BOLD response is thought to be mostly affected by changes in venous blood 
volume (CBVv) (Buxton et al., 1998) most imaging methods measure total CBV as a 
proxy for CBVv. Recent hypercapnia studies in rat models reported a substantial arterial 
component (~36%) to total blood volume change (Lee et al., 2001). If this arterial 
contribution is neglected, the estimated response in oxidative metabolism for a given 
BOLD signal will be underestimated. New independent quantification methods 
(Stefanovic and Pike, 2005) that specifically target venous CBV would help understand 
the mechanism of BOLD fMRI. 
 
BOLD signal models 
Given the complex and ambiguous nature of the BOLD signal, an accurate model of the 
vascular and metabolic contributions to signal would be useful to better understand 
differences across brain regions and groups. Over the years, there are two categories of 
models that have evolved: some focus on the dynamic aspects of the BOLD signal such 
as the BOLD signal time course and the post-stimulus undershoot; while others attempt 
to separate the steady-state physiological components, e.g. with respiratory 
calibrations. This review will address dynamic models only superficially and focus on the 
steady-state models, although we refer the reader to other reviews on dynamic models 
(Buxton, 2010, 2012). The theory for calibrated fMRI has previously been reviewed 
(Blockley et al., 2013; Pike, 2012), but here we describe recent, advanced methods for 
baseline oxygenation with calibrated BOLD models and later describe considerations for 
its use in disease. 
 
Dynamic models of the BOLD signal 
One family of dynamic models for the BOLD time course has followed the original 
formulation by Buxton et al. of the so-called balloon model (Buxton et al., 1998). This 
model stems from the principles that (1) CBF increases more than CMRO2 during the 















arteries is tightly controlled, the diameter of veins is purely a passive reflection of flow 
pressure. A review of this class of modelling can be found in (Buxton, 2012). A similar 
biophysical model was developed by Mandeville et al. to explain the underlying 
physiology responsible for delayed vascular compliance, which recreates the BOLD 
signal undershoot (Mandeville et al., 1999). 
Expansions of these models have been informed by a more complex picture of the 
hemodynamic process (Aubert and Costalat, 2002; Aubert et al., 2007; Blockley et al., 
2009; Buxton et al., 2004; Feng et al., 2001; Kong et al., 2004; Toronov et al., 2003; 
Uludag et al., 2009; Zheng and Mayhew, 2009). For example, newer dynamic models 
proposed by Havlicek et al. incorporate feed-forward neurovascular coupling that 
connects neural activity to blood flow, a balloon model that accommodates vascular 
uncoupling between CBF and CBV (Havlicek et al., 2015), and can synthesize BOLD 
data with CBF data collected concurrently during the same functional task (Havlicek et 
al., 2017b). Evidence that CMRO2 may be elevated after the end of a stimulus 
(Donahue et al., 2009; Hua et al., 2011) suggests an alternative reason for the BOLD 
signal undershoot; but remains a topic of current debate as other studies indicate that 
CBF-CBV uncoupling causes the undershoot (Chen and Pike, 2009b, 2010; Havlicek et 
al., 2017a). Further evidence that tissue pO2 is not as close to 0 as originally postulated 
(Devor et al., 2011) has also led to sophisticated modifications of BOLD dynamic 
models. These models and advanced bottom-up biophysical models (Gagnon et al., 
2015) are valuable to predict the BOLD signal and validate existing physiological 
interpretations of the signal.  
Calibrated fMRI models 
Calibrated fMRI is a family of techniques used to estimate oxidative metabolism in the 
brain, using a combination of a steady-state BOLD biophysical model and a respiratory 
manipulation. While this formulation was originally developed as a biophysical model of 
the BOLD signal, a more recent understanding of the complexity of neurovascular 
coupling has led calibrated fMRI to be viewed as a useful heuristic simplification 
(Buxton, 2012; Gagnon et al., 2016; Griffeth and Buxton, 2011). Calibrated fMRI 
enables experimental measurement of the BOLD signal sub-components and 
metabolism, and its predictions are in good agreement with more complex biophysical 
models (Griffeth and Buxton, 2011), especially when the assumed parameters are used 
as heuristic constants (Gagnon et al., 2016; Griffeth and Buxton, 2011). 
The original calibrated fMRI models allowed the measurement of task-evoked changes 
in cerebral metabolic rate of O2 consumption (CMRO2). Recent developments have 
however focused on measurement of resting CMRO2. Measurement of task-evoked 
oxidative metabolism provides quantitative estimates of CMRO2 which can help us 
understand functional differences across groups even if they have different vascular 
properties, such as older compared to younger adults (Ances et al., 2009; Gauthier et 
al., 2013; Mohtasib et al., 2012) or in certain diseases such as dementia and HIV 
(Ances et al., 2011). As a quantitative approach, baseline oxidative metabolism 
mapping may be more powerful as a potential biomarker in diseases with altered 
oxygen extraction fraction (OEF), including stroke, carotid occlusion, aging, dementia 
and other cerebrovascular diseases (Aanerud et al., 2012; De Vis et al., 2015a; De Vis 
















In the calibrated fMRI model proposed by Davis et al. (Davis et al., 1998) and described 
by Hoge et al. (Hoge et al., 1999), a hypercapnia manipulation is used to evoke a 
putatively purely vascular BOLD signal change. One of the main assumptions of this 
model is that breathing moderate CO2 concentrations on the order of 5% causes 
vasodilation and increases blood flow without changing oxidative metabolism. During 
the hypercapnia challenge, a dual echo sequence is typically used to measure CBF with 
ASL (at a short echo) and BOLD contrast at a longer echo (~30 ms at 3T) that optimizes 
sensitivity to the BOLD signal. The CBF and BOLD measurements are used as inputs 
into the hypercapnia model model (Davis et al., 1998; Hoge et al., 1999) to estimate M, 
a calibration parameter. M corresponds to the maximum possible BOLD signal change 
and is equivalent to the BOLD signal one would measure if all the dHb present at 
baseline were removed from the voxel. The hypercapnia model relates these quantities 
as follows: 
             Equation 1 
There are four assumed parameters in the hypercapnia model. Alpha represents the 
CBF to CBV coupling ratio, which was typically assumed to be uniform throughout the 
brain and across individuals. More recent studies have directly measured the exponent 
relating CBV and CBF in humans, e.g. with VERVE MRI to focus on venous instead of 
total blood volume (Chen and Pike, 2009a, 2010). The value for the alpha parameter is 
now thought to be around 0.18 – 0.20, lower than in the original experiment by Grubb et 
al. (0.38). Beta represents the field-dependent influence of dHb on transverse relaxation 
(Boxerman et al., 1995) and is assumed to be 1.3-1.5 at 3T (Bulte et al., 2009; Gauthier 
et al., 2013; Hare et al., 2015). More recent approaches treat Equation 1 as a heuristic 
model and estimate alpha and beta as heuristics constants without a specific 
physiological interpretations (Gagnon et al., 2016; Griffeth and Buxton, 2011). In these 
heuristic models, alpha and beta are found to have lower values than their original 
biophysical values. 
A third assumed parameter is that arterial blood is fully oxygen saturated, and arterial 
oxygen saturation tends to be > 97% in healthy adults even in slightly hypoxic 
conditions (Lu et al., 2012). However, measurements of oxygen tension have recently 
suggested that a relatively large amount of oxygen exits in pial arterioles prior to 
reaching the capillary bed (Vazquez et al., 2010), and assuming arterial O2 saturation 
may be problematic in disease populations (Bernardi et al., 2017; Ogburn-Russell and 
Johnson, 1990; Vold et al., 2014). Finally, the assumption of iso-metabolism during the 
hypercapnia manipulation may be somewhat problematic as there are indications that 
even moderate CO2 concentration may suppress oxidative metabolism (Xu et al., 
2011b; Zappe et al., 2008). 
The hypercapnia model also describes the relationship between M and CMRO2 evoked 















have the same values as before), and the BOLD and CBF responses during a functional 
task: 
 
All subsequent versions of the model use this equation to relate M to task-evoked BOLD 
signal, ASL and CMRO2.  
Hyperoxia model 
Because even moderate concentrations of CO2 can cause dyspnea and discomfort, a 
related model was developed using hyperoxia instead of hypercapnia for calibration. 
The hyperoxia method (Chiarelli et al., 2007) also assumes that the breathing 
manipulation does not affect the rate of oxidative metabolism. This assumption is also 
debated and there are indications that while elevated O2 concentrations may not be 
perceptible, they may nevertheless impact oxidative metabolism (Xu et al., 2011a). One 
of the main differences of the hyperoxia model is how it takes into account CBF to 
derive an estimate of M. Elevated inspired O2 concentrations do not have a large effect 
on CBF, so the CBF change is usually assumed in this technique. Relatively low O2 
concentrations are typically used to avoid significant vasoconstriction (Chiarelli et al., 
2007; Mark et al., 2011) and the decreased CBF that may occur in fixed-inspired 
hyperoxia manipulations (Fan et al., 2016; Gauthier and Hoge, 2012a). Therefore, in 
most implementations, the CBF change is assumed to be 0. In the hyperoxia model, M 
is calculated using the BOLD signal, an assumed CBF change, expired O2 
concentrations, and assumed constants. The assumed constants are baseline oxygen 
extraction fraction (OEF), used to calculate the venous dHb concentration, as well as 
the same alpha and beta constants present in the hypercapnia model.  
   Equation 3 
The hyperoxia technique has been used to study aging-related cognitive changes 
(Mohtasib et al., 2012). This model has been shown to have a reduced measurement 
variance compared to the hypercapnia technique (Gauthier and Hoge, 2012a; Mark et 
al., 2011). This lower variability is due to the fact that flow changes are assumed rather 
than measured when calculating M. There are, however, indications that this 
assumption leads to systematic underestimation of the M parameter and thus 
underestimation of the CMRO2 change during a task (Gauthier and Hoge, 2012a).  
Generalized calibration model 
Following the development of the hyperoxia model, modifications to generalize this 
approach for both hypercapnia and hyperoxia led to formulation of the generalized 















hyperoxia calibration model to include CBF in the equation relating the arterial and 
venous concentrations of O2:  
       Equation 4 
This modification allows the GCM model to be used any arbitrary combination of 
changes in O2 and CO2. Because both CBF and expired O2 concentrations are used to 
calculate M, estimates of M obtained using the GCM have been shown to be more 
stable (Gauthier and Hoge, 2012a) and more similar to directly measured M values 
(Gauthier et al., 2011) than the hypercapnia and hyperoxia models. 
Baseline CMRO2 mapping with respiratory calibration and BOLD signal 
Baseline oxidative metabolism has been shown by PET to be affected in several 
diseases, but there is no gold standard to non-invasively measure regional CMRO2 with 
MRI. The most established imaging technique is triple 15O-PET, which uses 15O-labelled 
H2O, O2 and CO to measure OEF, CBF and CMRO2 (Ishii et al., 1996a; Ishii et al., 
1996b; Ito et al., 2004; Yamaguchi et al., 1986). PET studies using this technique have 
shown metabolic changes in stroke (Yamaguchi et al., 1986), dementia (Nagata et al., 
2000) and Alzheimer’s disease (Ishii, Kitagaki et al. 1996). Unfortunately, 15O-
radiotracers have a half life of 2 minutes, so PET measurement of oxidative metabolism 
requires specialized equipment, complex setup, and invasive arterial blood sampling for 
quantification. These constraints make 15O-PET difficult to implement in clinical settings 
and in most research institutes. 
In recent years, MRI techniques have been developed to measure baseline OEF and 
CMRO2 from calibrated BOLD. In the original hyperoxia and GCM biophysical models, 
the value of the resting OEF is explicitly assumed. Instead of assuming baseline OEF, 
several groups have modified the BOLD model to measure OEF through use of multiple 
respiratory calibrations. This would allow calibrated fMRI to be used not only for 
mapping task-evoked metabolism, but also baseline metabolism (Bulte et al., 2012; 
Gauthier and Hoge, 2012b; Wise et al., 2013). 
The dual-calibration method proposed by Bulte et al. (Bulte et al., 2012) uses two 
breathing manipulations (hypercapnia and hyperoxia) and simultaneously measures 
BOLD signal, ASL and end-tidal O2 values. The BOLD and ASL signals during the 
hypercapnia manipulation are first used to measure M with the hypercapnia model 
(Davis et al., 1998). This M value is then combined with BOLD and end-tidal O2 
measurements from a separate hyperoxia manipulation to estimate baseline OEF, 
instead of assuming OEF as in the original hyperoxia model (Chiarelli et al., 2007). OEF 
can then be combined with resting CBF from a baseline ASL measurement to estimate 
resting CMRO2 through the Fick principle (Kety and Schmidt, 1948). This approach 
relies on two sets of assumptions (from the hypercapnia and hyperoxia models) to 
measure M and OEF, and has been used to study aging and carotid occlusion (De Vis 















Gauthier and Hoge proposed an alternative approach to map baseline CMRO2 based 
on the GCM, which uses two or more breathing manipulations to measure OEF and M 
simultaneously (Gauthier and Hoge, 2012b). The GCM can be expressed as the 
relationship between measured quantities (BOLD signal, ASL and end-tidal O2), with 
two unknown parameters (M and OEF). This equation can be adapted for any breathing 
manipulation with changes in CO2, O2 or both. Therefore, by performing two or more 
breathing challenges, both unknowns OEF and M can be estimated. Because the 
measurements rely on a non-linear combination of low-SNR measurements such as 
ASL, three gases are sometimes used to increase the reliability of estimates (Fan et al., 
2016; Gauthier et al., 2012; Gauthier and Hoge, 2012b).  
A similar generalized, calibrated fMRI approach was subsequently proposed by Wise et 
al. ( Wise et al., 2013) to simultaneously measure M, OEF and CMRO2 using more 
complex hypercapnic and hyperoxic manipulations. These breathing manipulations 
combine several levels of O2 and CO2 inhalations to provide a more complete picture of 
the relationship between BOLD signal, CBF, and end-tidal O2, with OEF and CMRO2. It 
furthermore allows estimation of the α and β parameters or a heuristic combination of 
the two (Merola, Murphy et al. 2016). This generalized model has also been 
implemented in a Bayesian statistical framework to improve reliability in low-SNR 
conditions, yielding promising and stable estimates of M, OEF and CMRO2 (Germuska, 
Merola et al. 2016). 
Potential sources of error as well as the reproducibility of baseline oxygenation mapping 
with calibrated BOLD models have been explored (Fan et al., 2016; Lajoie et al., 2016; 
Leontiev and Buxton, 2007). Technical considerations of the dual-calibration approach 
and their impact on estimates of metabolism were simulated by Blockley et al. (Blockley 
et al., 2015). The most problematic assumptions identified in healthy volunteers were 
the assumption of iso-metabolism under hypercapnia and the assumption of a small or 
non-existent CBF change during hyperoxia. Small deviations in these assumptions were 
found to lead to significant errors in OEF estimates. A recent 7 Tesla MRI study 
observed 8% variation in CMRO2 between adjacent scans and 33% variation across 
days (Krieger et al., 2014). In practice, quantification from calibrated BOLD models will 
depend on field strength. For instance, BOLD signals at higher magnetic fields (e.g, 7T) 
are more sensitive to microvasculature instead of larger veins, which corresponds to a 
smaller beta parameter (β~1) in the model. The BOLD contribution also 
disproportionately decreases the sensitivity of ASL at higher field strengths, which 
propagates error into CMRO2 estimates (Lu et al., 2006). Nonetheless, BOLD 
calibrations such as hypercapnia have been shown to provide consistent normalizations 
across field strengths and pulse sequences, suggesting that use of multiple respiratory 




Baseline oxygenation mapping by quantitative BOLD (qBOLD) and vascular fingerprinting 
 
Independent quantitative BOLD (qBOLD) approaches have been developed to model 
the BOLD magnitude signal and relaxation times (T2*, T2, T2’) in tissue and map 















field inhomogeneities created by dHb molecules in microvasculature, and are thus 
sensitive to oxygenation levels. The T2’ parameter, which is the reversible component of 
transverse relaxation and defined as 1/T2’ = 1/T2* - 1/T2, is the most directly related to 
oxygenation (Yablonskiy and Haacke, 1994). New hybrid sequences combine gradient 
and spin echo (multi-echo) acquisitions allow estimation of T2*, T2, and T2’ from the 
same scan (Ni et al., 2015; Yablonskiy and Haacke, 1997). These hybrid sequences 
enable mapping of relaxation parameters that are sensitive to the underlying 
oxygenation state of the brain. The GESFIDE (gradient-echo sampling of free induction 
decay and echo) sequence provides more repeatable R2’ measurements compared to 
the original asymmetric spin echo sequence (Figure 1d) (Ni et al., 2015). 
A major challenge of extravascular BOLD methods is that relaxation parameters are not 
specific to brain oxygenation. For instance, even T2’ is the product of deoxygenated 
blood volume (DBV) and dHb-induced frequency shifts, and complex biophysical 
models are required to extract baseline oxygenation. Early quantitative BOLD (qBOLD) 
approaches have focused on the T2’ signal from gradient- and spin-echo acquisitions. 
These methods model capillary vessels in brain parenchyma as a network of randomly 
oriented cylinders to describe MRI signal dephasing in the presence of dHb: 
R2’ = DBV · δω = DBV · γ · 4/3 · pi ∆χ0 · 0.03 [dHb] B0   Equation 5 
 
where δω is the characteristic frequency, γ is the gyromagnetic ratio, ∆χ0 is the 
susceptibility difference between fully oxygenated and fully deoxygenated red blood 
cells, [dHb] is the hemoglobin concentration, and B0 is the field strength. By fitting the 
signal model at each voxel, qBOLD techniques create parametric maps of venous 
oxygen saturation (SvO2) and CMRO2. Some qBOLD implementations assume a single 
extravascular tissue compartment (An and Lin, 2000; An et al., 2001), while others also 
consider blood and cerebrospinal fluid (CSF) compartments in the model fit to each 
voxel (Christen et al., 2012; He and Yablonskiy, 2007; He et al., 2008). Recent 
streamlined approaches consider the monoexponential and quadratic behaviors of 
transverse MR signal decay to separate OEF from blood volume effects on BOLD signal 
(Figure 1e) (Stone and Blockley, 2017). The accuracy of qBOLD models also benefit 
from prospective correction for macroscopic field inhomogeneities (Blockley and Stone, 
2016) and FLAIR suppression of CSF signal as confounders. 
A novel extension of the qBOLD class of methods is vascular fingerprinting. Christen et 
al. proposed a vascular fingerprint that simulates a dictionary of signal curves based on 
gradient- and spin- echo acquisition (Figure 1f). Each dictionary entry corresponds to 
the signal that would arise for specific combination of cerebral blood volume, mean 
vessel radius, and SvO2 of microvasculature in a voxel (Christen et al., 2014). The 
actual measured signal is matched to the best-fit dictionary curve, which reveals a 
specific quantitative SvO2 value (and other physiology) for tissue in the voxel. Design of 
efficient and orthogonal fingerprints (BOLD acquisition patterns) and use of realistic 
vessel models (e.g. from high-resolution optical microscopy, (Pouliot et al., 2017)) will 

















Future directions for oxygenation measurement from BOLD signal should also include 
validation with other modalities (PET and NIRS) and with alternative MRI methods. 
These MRI methods use different contrast mechanisms from BOLD, including T2 
measurements in isolated venous blood (Bolar et al., 2011; Lu and Ge, 2008) and 
phase / susceptibility measurements in individual cerebral veins (Fan et al., 2011; Jain 
et al., 2010) or parenchyma (Zhang et al., 2016). These distinct oxygenation MRI 
methods have been reviewed in detail (Christen et al., 2013; Rodgers et al., 2016; 




BOLD signal quantification in neurological disease 
As described in the biophysical models above, extensive neuroscience investigations 
have sought to model and predict the BOLD signal from its quantitative components, 
including blood flow, blood volume, and blood oxygenation (Cheng and Haacke, 2001; 
van Zijl et al., 1998). However, these models have focused on normal physiology in 
functional activity, and are challenging to apply in disease settings. In various 
neurological disorders, pathological processes will perturb multiple physiological 
parameters, which are difficult to disentangle from a single BOLD measurement. 
In tumours, for instance, BOLD MRI has been proposed as a proxy biomarker for tissue 
oxygenation, especially during interventions that seek to enhance the radiation 
response of poorly oxygenated tumours (Dunn et al., 2002). Unfortunately, the BOLD 
signal alone cannot be used to assess absolute oxygenation. Previous studies in mice 
models found no correlation between BOLD signal and direct pO2 measurement (with 
micro-optic probes) across tumours (Baudelet and Gallez, 2002); e.g. a given BOLD 
signal change could correspond to 25 mmHg pO2 change in one tumour but to 100 
mmHg pO2 change in another tumour. Similarly, baseline pO2 did not relate to the 
baseline T2* (BOLD-weighted) signal. Interpreting BOLD contrast as a biomarker of 
oxygenation is thus an over-simplification, likely because it neglects the flow weighting 
in the signal. 
Cerebrovascular reactivity 
On the other hand, fluctuations in BOLD signal do correlate over time with pO2 changes 
(Hallac et al., 2014), suggesting that BOLD responses to manipulations (such as 
carbogen breathing) can inform scientists and clinicians about the physiological 
response in individual tumours (Taylor et al., 2001). Monitoring the hemodynamic 
response to different gas challenges, such as a hyperoxia and hypercapnia, may allow 
discrimination between tumours and healthy tissue, and between different tumour types 
(Ben Bashat et al., 2012). In fact, a negative BOLD response during hypercapnia (which 
increases blood flow globally to the brain) has been observed in tissue distal to the 
tumour location (Ben Bashat et al., 2012). This negative response is indicative of steal 
phenomenon, in which blood flow is shunted away from ischemic areas that lack auto-
regulation of flow. In this case, the BOLD signal change is dominated by the flow 















These observations in tumours are echoed by findings in cerebrovascular disease; 
BOLD increases during gas breathing or during a pharmacological (acetazolamide) 
challenge in steno-occlusive patients strongly correlate with quantitative perfusion 
changes (De Vis et al., 2015b; Mandell et al., 2008). Comparing the cerebrovascular 
reactivity (CVR) in response to a “stress challenge” between patient groups is more 
appropriate than a direct comparison of baseline BOLD signal, and can help interpret 
separate BOLD observations during a functional task. For instance, “normal-appearing” 
tissue areas in patients with stroke were found to have the same CVR as control 
subjects (Geranmayeh et al., 2015). In these normal-appearing regions, any group-level 
BOLD signal changes during a functional task is likely neuronal in nature, if baseline 
CBF is also unaffected. 
In the same stroke patients, CVR was reduced in tissue near the infarct, but this CVR 
level was maintained throughout multiple repeated sessions. As CVR measurements 
were repeatable, longitudinal group-level BOLD changes during the functional task were 
confidently attributed to neuronal changes in the stroke patients (e.g. recovery over 
time) instead of vascular changes (Geranmayeh et al., 2015). On the other hand, large 
BOLD CVR differences have been measured between APOE ε2- and ε4- gene carriers, 
who are at higher risk of Alzheimer’s dementia, versus non-carriers. These genotype 
differences in CVR accounted for 70% of hippocampal BOLD differences between 
groups during a functional memory task (Suri et al., 2014), suggesting that a task-
evoked BOLD experiment alone cannot capture APOE’s effect (likely vascular) on risk 
for Alzheimer’s disease. 
BOLD contrast combined with physiological imaging 
The most informative patient studies have paired BOLD measurement with additional 
physiological scans to monitor specific sub-components of the BOLD signal. As a case 
study, vascular impairment is a known feature of cognitive aging in healthy adults 
(Snyder et al., 2015), but the same neurovascular coupling factor (from neuronal activity 
to hemodynamic response) is still often assumed in both young and elderly people. 
During a cognitive task, measured BOLD responses in the frontal cortex were similar 
between younger (mean age 24) and older adults (mean age 64) (Gauthier et al., 2013), 
which could naively be interpreted as the same level of neuronal activity in each group. 
However, the investigators also measured brain perfusion with arterial spin labeling 
(ASL) in the same session, and observed 5% reduced CBF response to hypercapnia in 
elderly people. Through quantification with the calibrated BOLD model, older adults 
were found to have 15% lower maximal BOLD response (M) compared to younger 
adults (Gauthier et al., 2013). These additional ASL-based findings suggest that a given 
BOLD response in elderly people might correspond to a larger change in neuronal 
activity than the same measured BOLD response in younger people. Reduced absolute 
CBF in elderly cohorts (age 60-78 years) was confirmed by separate dual-echo 
BOLD/ASL experiments compared to younger cohorts (24-33 years) (De Vis et al., 
2015a). Through the general calibrated model, these BOLD/ASL experiments also 
revealed lower CMRO2 in elderly cohorts, presenting both vascular and metabolic 
baseline differences that influence the BOLD signal. Auxiliary physiological scans such 
as ASL or direct OEF imaging thus are needed to interpret BOLD responses when 















Finally, even more nuanced understandings of BOLD signals are made available with 
quantitative CBF scans. Baseline CBF and the neurovascular coupling constant 
(between CMRO2 and CBF) both directly affect the BOLD signal amplitude; and there is 
evidence that the coupling constant itself is sensitive to baseline CBF (Whittaker et al., 
2016). In addition to the mean BOLD signal, the standard deviation is also reduced in 
some populations including elderly people, indicative of impaired hemodynamic range 
(Garrett et al., 2017). Using simultaneous BOLD/ASL scans, a recent study corrected 
for vascular effects (CVR, CBF) on the standard deviation of the BOLD signal. Even 
after this correction, older adults still had lower BOLD variability compared to younger 
adults (Garrett et al., 2017). With ancillary ASL scans, vascular effects can thus be 
decoupled, revealing neuronal-specific changes in BOLD signal and BOLD variability 
that are important biomarkers of aging and neurological disease. 
Given this understanding of the BOLD biophysical models, investigators can follow the 
following principles: (1) Acknowledge that multiple physiological components can 
change in disease and contribute to BOLD signal differences between patients. (2) 
Because neurovascular coupling can change for various patient groups, e.g. in elderly 
versus young patients (D'Esposito et al., 2003), test for relative BOLD differences 
between groups. For instance, BOLD changes during multiple behaviour or breathing 
tasks are more informative than comparing patient BOLD responses to a single task or 
at baseline. (3) Whenever possible, inform the interpretation of the BOLD signal with 
separate measurements of baseline physiological quantities in the same imaging 
session, as detailed in Figure 2. 
 
Considerations for use of quantitative BOLD models in patients 
 
The use of calibrated BOLD models that enable baseline OEF mapping provides the 
most complete information, but also complex errors in disease applications. Because 
these models were originally formulated for normal physiology, the use of additional 
BOLD observations for calibration is difficult when cerebral physiology, or interactions 
between the physiological parameters (e.g. CBV and CBF), are perturbed in disease. 
Furthermore, many neurological disorders such as tumors are thought to exhibit 
extremely heterogeneous values of OEF and CMRO2. If the assumed CBF change 
(e.g., in the hyperoxia model) or assumed neurovascular coupling is spatially uniform, 
the calibrated BOLD model results will not capture the true physiological heterogeneity 
in the tumor. 
 
Table 1 addresses the major assumptions of the calibrated BOLD model and the 
potential error that results if these assumptions are not met in disease settings. The 
assumed coupling between CBV and CBF is likely the most problematic because 
changes in this coupling are often regional in nature (Eastwood and Provenzale, 2003; 
Peca et al., 2013) and depends on disease stage (Leigh et al., 2017). Especially in 
conditions where CBV and CBF are decoupled (e.g. a lack of autoregulation), results of 
the calibrated BOLD model will not be interpretable. Other assumptions of iso-















expected to create global measurement bias that can be corrected, or reduced 
sensitivity that requires higher SNR in the acquisition. A major strength of the calibrated 
BOLD methods is that the underlying models can be easily adapted to non-ideal 
conditions, given prior information about the brain physiology. For instance, when the 
iso-metabolic assumption is not met, known changes in metabolism (e.g. from literature 
or other quantitative MRI scans) can be accounted for in Equations 2 and 3. 
 
To select between different quantitative BOLD methods, investigators may first consider 
what is known a priori about neurovascular coupling in the specific disorder. If CBV and 
CBF changes are severely decoupled, or will change rapidly over the disease course, 
the calibrated BOLD model may not be appropriate. Instead, the investigators can 
consider adoption of more specific physiological imaging techniques, such as imaging 
CBV directly with VASO-based techniques instead of deriving CBV changes from ASL 
observations of perfusion. Vascular fingerprinting methods may also be a viable 
alternative if contrast is used for acquisition, enabling separation of CBV and 
oxygenation effects and a more flexible dictionary that accommodates disruptions to 
neurovascular coupling (Christen et al., 2014). Secondly, if OEF and CMRO2 changes 
are spatially heterogeneous in the disease, investigators should avoid purely hyperoxic 
calibrations that assume a uniform CBF response. Instead, the investigators may 
prioritize carbogen and hypercapnic calibrations within an acquisition protocol that 
enables sufficient spatial resolution in the BOLD-ASL scan. 
 
Conclusion 
The BOLD signal is a valuable tool for detecting changes in neuronal activity in the 
human brain. While the BOLD signal is related to neuronal activity, the relationship 
between them is complex, involving a combination of changes in oxidative metabolism, 
blood flow and blood volume. Various models have been developed over the years to 
describe BOLD signal dynamics and its steady-state physiological component. One of 
the most useful BOLD signal models is the calibrated fMRI model. This model uses a 
hypercapnia manipulation to extract the vascular and metabolic components of this 
signal. Since its original description, this model has been extended to be valid for other 
breathing manipulations such as hyperoxia and carbogen breathing. More recent work 
has further extended the use of this model to measure baseline oxidative metabolism. 
The BOLD contrast and BOLD signal models can be used in the clinic to study tumours 
and cerebrovascular diseases. These quantitative models are especially useful for the 
understanding of cerebral diseases as they are more specific biomarkers of clinically-
relevant physiological changes.  
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Figure 1. Methods to quantify oxygenation from the BOLD signal 
(A) Respiratory calibration approaches acquire BOLD signal, ASL (perfusion), and end-
tidal gas measurements during multiple gas challenges, including hyperoxia, 
hypercapnia, and / or carbogen. (B) The analysis is performed with a dual-calibration 
approach, which first estimates the M parameter (maximum achievable BOLD) signal 
from the hypercapnia scan and then estimates baseline OEF from the hyperoxia scan 
(Bulte et al., 2012). (C) Alternatively, the generalized calibration model describes 
relationships between M and baseline OEF for any combination of gases, and estimates 
OEF from the curve intercept (Gauthier and Hoge, 2012b). 
(D) Independently, quantitative BOLD approaches acquire spin- and gradient- echo 
sampling of the BOLD signal. These sequences include asymmetric spin echo (ASE) 
and GESFIDE (gradient-echo sampling of free induction decay and echo) (Ni et al. 
2015). (E) The multi-echo time course can then be fit to the quantitative BOLD model, 
which includes considers both OEF and deoxygenated blood volume (DBV) effects on 
the signal (Stone and Blockley, 2017). (F) In a fingerprinting approach, the signal time 
course can instead be matched to a best-fit curve in a simulated dictionary (Christen et 
al., 2014). This best-fit vascular fingerprint reveals the underlying OEF, vessel radius, 
and CBV of the voxel. 
 
Figure 2. BOLD quantification in disease 
Disease-related changes to the BOLD signal amplitude may be driven by differences in 
neuronal activity or by vascular differences between patients (red) and healthy controls 
(blue). With an additional arterial spin labeling (ASL) MRI scan, baseline CBF can be 
measured in the same imaging session. Reduced perfusion in some patients accounts 
for lower BOLD signal, including in several neurodegenerative diseases and cognitive 
aging. With a single hypercapnia challenge, the change in BOLD or ASL signal during 
gas breathing reveals the cerebrovascular reactivity of brain tissue. If both BOLD and 
ASL contrasts are acquired during hypercapnia, quantitative modeling reveals the M 
parameter (maximum achievable BOLD signal) and task-driven change in cerebral 
metabolic rate of oxygen (CMRO2). Physiological MRI during hypercapnia thus 
assesses whether neurovascular coupling and the oxygen metabolic response is 
preserved or impaired in patients, which would reduce the BOLD signal. Finally, with 
multiple respiratory calibrations, quantitative maps of baseline oxygen extraction fraction 
(OEF) and CMRO2 are available to control the BOLD signal for oxygen metabolism or 
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Table 1. Measurement effects if the assumptions of the calibrated BOLD model are not met in disease conditions 
 
Assumption Breakdown and Example Neurological Disorder Resulting Error 
CBF to CBV coupling 
• Elevated coupling ratio: Tumors show elevated 
CBV that is disproportionate to the CBF increase. 
(Akella 2004, Eastwood 2003) 
• Uncoupling: In stroke penumbra and steno-
occlusive disease, reduced CBF is compensated 
initially by vessel dilation and increased CBV 
(Leigh 2017) 
• Changes in coupling ratio will lead to measurement 
bias. For instance, overestimation of changes in 
CMRO2 occurs if increased coupling ratio is not 
accounted for (Davis 1998). 
•  
• When uncoupling is suspected, it is not appropriate to 
estimate CBV from the CBF response. Alternative 
CBV imaging strategies should be used with the 
model. 
Iso-metabolism during 
mild CO2 or O2 inhalation 
 
• Assumed iso-metabolism during gas challenges 
is debated even in healthy people, and may be 
more problematic in patients.  
• Prolonged increases in CMRO2 after hyperoxia 
treatment have been shown specifically in tumor 
tissue. (Rockswold 2001, Rijpkema 2002) 
• Decreased CMRO2 is observed with hyperoxia 
treatment for global ischemia after cardiac arrest, 
reflecting damage from oxidative molecular 
changes (Richards 2007). 
 
• If metabolism changes during the gas challenge, the 
resulting M parameter is not an appropriate 
calibration. 
• If CMRO2 increases during gas breathing instead of 
remaining constant, the M parameter will be 
overestimated. This translates to overestimation of 
CMRO2 changes during a separate functional task.  
• Calibrated BOLD methods that use multiple gas 













Arterial blood is fully 
saturated 
• The calibrated BOLD models assume that 
arterial blood is fully oxygenated, but anemic or 
elderly / diabetic populations may have lower 
arterial oxygenation. 
• Similarly, the carrying capacity of oxygen is 
different for sickle cell populations with altered 
hemoglobin conformations. 
• In the hyperoxia model, the relationship between 
measured end-tidal O2 and the arterial content may 
not be accurate in patients 
• For quantification, CaO2 (arterial O2 content) is 
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